Based on 784 businesses audited.
Medical Devices, Pharma & Biotech Reputation: EUCRISA (Pfizer) (eucrisa.com)
EUCRISA is a high-substance pharmaceutical site that suffers from technical neglect and template fatigue. While the clinical and financial claims are specific and well-documented, the null schema and ‘corona msg’ artifacts suggest a brand operating on autopilot. It is low on marketing bullshit but moderately high on technical ‘ghost-brand’ indicators.
Medical Devices, Pharma & Biotech Reputation: EUCRISA (Pfizer) (eucrisa.com)
The content perfectly matches the Pharma & Biotech category, specifically focusing on a prescription topical treatment (crisaborole) for atopic dermatitis. It adheres to pharmaceutical regulatory norms by including extensive ‘Important Safety Information’ (ISI) and specific ‘Indication’ blocks.
“The score of 62 is driven primarily by technical authority gaps (null schema) and trust theatre flags (unverified reviews). While the content substance is strong (lowering the score), the presence of template artifacts and the lack of external proof paths prevent it from reaching a 'Minimal BS' rating. The 2026 temporal anchor makes the 2016 approval date appear 'stale,' further contributing to the technical neglect penalty.”